Trials / Sponsors / Satsuma Pharmaceuticals, Inc.
Satsuma Pharmaceuticals, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment o Migraine, Migraine With Aura, Migraine Without Aura | Phase 3 | 2021-06-30 |
| Completed | A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects Migraine, Migraine With Aura, Migraine Without Aura | Phase 1 | 2021-03-05 |
| Completed | A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine Migraine, Migraine With Aura, Migraine Without Aura | Phase 3 | 2020-09-14 |
| Completed | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine Migraine, Migraine With Aura, Migraine Without Aura | Phase 3 | 2019-06-24 |
| Completed | A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Migraine With Aura, Migraine Without Aura, Migraine | Phase 1 | 2018-09-11 |